Companies in this catalog do not charge applicants. Never send money to apply.
Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website or follow us on LinkedIn.
We are currently seeking a dynamic, highly motivated, and experienced individual for the position of Global Value and Access Director – Regenerative Medicine. This individual will lead execution of market access, pricing, and reimbursement plans across global markets outside the US for regenerative medicine assets, while providing strategic input into the central global access strategy, value framework, and pricing guardrails. This role will partner with the Senior Director, Global Commercial and Market Access Strategy on OUS access strategy, evidence and value planning, cross-functional launch readiness, and early payer/access considerations across priority markets. This individual will work with the global cross-functional team and external partners to ensure that access, reimbursement, and value considerations are embedded early and operationalized effectively.
The ideal candidate brings strong strategic market access experience, excellent cross-functional leadership skills, and the ability to translate complex clinical and operational realities into actionable value and reimbursement strategies in highly specialized or innovative therapeutic areas.
Job Duties and Responsibilities
Lead OUS Market Access Strategy and plan and an overall commercialization Execution Lead development and execution of OUS market access, pricing, and reimbursement strategies across priority OUS markets, aligned with centrally defined global strategy Translate overall global strategic objectives into actionable OUS launch plan including the market access workstreams, milestones, and deliverables aligned with global timelines Own and drive day-to-day execution of OUS market access priorities across assets, ensuring alignment to central strategy, timelines, and long-range plans.
Drive OUS launch readiness activities related to access pathways, reimbursement planning, and pricing implementation Identify market-specific access risks, reimbursement barriers, policy constraints, and operational dependencies that may impact OUS launch readiness or uptake Contribute to long-range planning for international access, including launch sequencing assumptions, affordability considerations, and stakeholder engagement priorities Provide structured ex-US market insights to inform global access strategy, evidence planning, and value narrative development HTA, Pricing, and Reimbursement Lead HTA planning and execution across priority markets, including EU JCA and relevant country-level reimbursement pathways Develop country-level pricing and reimbursement recommendations aligned with centrally defined pricing guardrails Support pricing and reimbursement negotiations in partnership with regional stakeholders, affiliates, and external partners as applicable Monitor international pricing, reimbursement, and policy developments—including reference pricing and analogous cross-market risks—and recommend mitigation strategies Represent ex-US access perspectives in cross-functional planning and governance forums, escalating key tradeoffs and recommendations as appropriate Accountable for OUS access outcomes, including HTA success, reimbursement readiness, pricing alignment, and time to market access
Who You Are
You are a highly motivated, engaging and team-oriented individual with a passion for problem solving and supporting clinicians and patients. You can lead without authority and organize impactful business meetings with the intent to develop and execute our strategy.
10+ years of progressive business experience in the healthcare, pharma or biotech industry, inclusive of global market access, pricing & reimbursement, value strategy, HEOR interface, or global commercial strategy; experience in cell, gene, and regenerative medicines a plus
Experience with EU markets and country-level HTAs, pricing and reimbursement; JCA experience preferred
Strong understanding of payer, reimbursement, HTA, and access dynamics in OUS settings
Ability to synthesize clinical, economic, operational, and policy information into clear strategic recommendations
Excellent communication, executive presence, and stakeholder management skills
Experience in rare disease, specialty therapeutics, biologics, cell therapy, gene therapy, tissue-based therapies, or other advanced modalities highly preferred
Experience partnering with regional teams, affiliates, distributors, or external commercialization partners
Comfort operating in a dynamic, ambiguous environment where access strategy must be developed in parallel with evolving clinical and regulatory plans
Must be comfortable spending 30% of time traveling; some overnight travel required
The base salary range for this role is
$196,400.00 - $245,500.00 Base salary is part of our total rewards package which also includes the opportunity for merit-based salary increases, short incentive plan participation, eligibility for our 401(k) plan, medical, dental, vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy includes flexible paid time off, 11 paid holidays plus additional time off for a shut-down period during the last week of December, 80 hours of paid sick time upon hire and each year thereafter. Total compensation, including base salary to be offered, will depend on elements unique to each candidate, including candidate experience, skills, education and other factors permitted by law.
Disclaimer: The above statements are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not to be construed as an exhaustive list of all responsibilities, duties, and skills required of personnel so classified. All personnel may be required to perform duties outside of their normal responsibilities from time to time, as needed.
Confidential Data: All information (written, verbal, electronic, etc.) that an employee encounters is considered confidential, in accordance with applicable law.
Compliance: Achieve and maintain Compliance with all applicable regulatory, legal and operational rules and procedures, by ensuring that all plans and activities for and on behalf of Sumitomo Pharma America (SMPA) and affiliates are carried out with the "best" industry practices and the highest ethical standards.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Mental/Physical Requirements:
Fast-paced environment handling multiple demands is involved. Must be able to exercise appropriate judgment as necessary. Requires a high level of initiative and independence. Excellent written and oral communication skills required. Requires ability to use a personal computer for extended periods of time.
Travel Requirements:
Primarily remote role with periodic on-site meetings in office. Must be able to travel domestically and internationally as needed.
Drug Screening Requirements
Applicants for sales/field, manufacturing, or other designated roles will be required to submit to a pre-employment drug test.
Sumitomo Pharma America (SMPA) is an Equal Employment Opportunity (EEO) employer
Qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
Sumitomo Pharma America (SMPA) endeavors to make its application process accessible to all. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process, please contact SMPA at . This contact information is for accommodation requests only and cannot be used to inquire about the status of applications.
